- ►duanessolution.com S Julien, P Heiduschka, S Hofmeister, U … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: In the optic nerve, immunoreactivity for bevacizumab was most prominent
on day 1 after injection and diminished rapidly. In the blood vessels of the
nerve fibre layer, the staining was intense in the walls and weak in the ... Cited by 2 - Related articles - All 5 versions
- ►prsjournal.com WAIMAN CHAN, TYY LAI, KP CHAN, H LI, … - Retina, 2008 - journals.lww.com 2 months (P 0.001). For the 17 eyes with myopic CNV, the mean ... 28.9 pg/mL at
baseline to 3.8 pg/mL ... 5.3 pg/mL at 2 months (P 0.016), whereas the mean
PEDF level increased from 20.0 ng/mL 16.3 ng/mL at baseline to 126.0 ng/mL ... Cited by 4 - Related articles - All 4 versions
AC Browning, WM Amoaku, AK Chung, F … - Ophthalmology, 2007 - Elsevier The patient demographics and baseline characteristics have been reported
previously. Sixteen eyes with subfoveal choroidal neovascularization and 7 with
juxtafoveal lesions at baseline were recruited. Twenty-two eyes of 21 ... Cited by 4 - Related articles - All 7 versions
KCS Fong, D Thomas, K Amin, D Inzerillo, SE … - Eye, 2007 - nature.com A prospective case series of patients with subfoveal CNV secondary to PIC was
analysed. All patients were treated with PDT combined with oral prednisolone (1
mg/kg body weight/day) which was started 5 days before PDT. Fluorescein ... Cited by 4 - Related articles - BL Direct - All 3 versions
RM Coco, CF de Souza, MR Sanabria - Ocular Immunology and Inflammation, 2007 - Informa Pharma Science Purpose: To evaluate the treatment of subfoveal and juxtafoveal choroidal
neovascularization (CNV) using verteporfin photodynamic therapy (vPDT) in
patients affected by punctate inner choroidopathy (PIC). Methods: A chart ... Cited by 4 - Related articles - BL Direct - All 7 versions
- ►prsjournal.com LJ Hernandez-Pastor, A Ortega, A Garcia- … - American Journal of Health-System Pharmacy, 2008 - pt.wkhealth.com LUIS JAVIER HERNANDEZ-PASTOR, PHARM D., is Resident, Pharmacy Department,
University Clinic; ANA ORTEGA, PHARM.D., PH.D., is Consultant Pharmacist,
Clinica Universitaria, and Assistant Professor, Faculty of Pharmacy; ... Cited by 5 - Related articles - All 8 versions
SY Lee, JG Kim, SG Joe, H Chung, YH Yoon - Korean Journal of Ophthalmology: KJO, 2008 - pubmedcentral.nih.gov Intravitreal bevacizumab was given alone in 8 eyes (Group 1) and in combination
with PDT in 4 eyes (Group 2). Mean follow-up duration was 17 weeks in group 1
and 15 weeks in group 2 after bevacizumab treatment. The mean number of ... Cited by 5 - Related articles - All 9 versions
HF FINE, I ZHITOMIRSKY, KB FREUND, GR … - Retina, 2009 - journals.lww.com HOWARD F. FINE, MD, MHSC,*† INNA ZHITOMIRSKY, BA,‡ K. BAILEY FREUND, MD,*
GAETANO R. BARILE, MD,† BELINDA L. SHIRKEY, MD,* C. MICHAEL SAMSON, MD,*
LAWRENCE A. YANNUZZI, MD* ... Background: Multifocal choroiditis (MFC) is ... Cited by 6 - Related articles - All 3 versions
- ►prsjournal.com TYY Lai, WM Chan, DTL Liu, FOJ Luk, DSC … - British Medical Journal, 2008 - bjo.bmj.com Results: The mean follow-up duration was 12.8 months. At 3 months, the mean
logMAR BCVA improved from 0.61 to 0.51 (p = 0.014), and the mean CFT reduced
from 347 μm to 247 μm (p = 0.015). Despite the visual and anatomical ... Cited by 5 - Related articles - BL Direct - All 5 versions
- ►duanesolution.com CN SINGH, DA SAPERSTEIN - Retina, 2008 - journals.lww.com Photodynamic therapy (PDT) with verteporfin has been shown to be effective
treatment for subfoveal choroidal neovascularization (CNV) due to age-related
macular degeneration (AMD).1,2 The main drawbacks of PDT are that the ... Cited by 6 - Related articles - BL Direct - All 3 versions
